Cenacitinib

N/A

Report date: 2025/12/25 15:59:20

NME

Base Information

Drug NameCenacitinib

Drug Alias NameVTX-958

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTyrosine-protein kinase 2 inhibitorsProtein allosteric inhibitors

TargetsTyrosine-protein kinase 2

Therapy Area/IndicationsPlaque psoriasisPsoriasisCrohn Disease +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCzechiaBulgariaCanada +[16]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsPlaque psoriasis

Inactive IndicationsPsoriasisCrohn DiseaseArthritis, Psoriatic

ATC CodeN/A